{
    "id": "36380551-b943-fff8-e063-6394a90a787f",
    "indications": "loxapine capsules indicated treatment schizophrenia . efficacy loxapine schizophrenia established enrolled newly hospitalized chronically hospitalized acutely ill schizophrenic patients subjects .",
    "contraindications": "loxapine capsules administered , usually divided doses , two four times day . daily ( terms base equivalents ) adjusted individual patient ’ needs assessed severity symptoms previous history response antipsychotic drugs .",
    "warningsAndPrecautions": "loxapine capsules , usp available following strengths : loxapine succinate , usp 6.8 mg equivalent 5 mg loxapine , black ink , hard shell , opaque , white body cap , printed “ watson 369 ” one half “ 5 mg ” , supplied ndc : 70518-0346-00 packaging : 30 1 blister pack store 20° 25°c ( 68° 77°f ) [ usp controlled room temperature ] . dispense tight , child-resistant container . repackaged distributed : remedy repack , inc. 625 kolter dr. suite # 4 indiana , pa 1-724-465-8762",
    "adverseReactions": "loxapine contraindicated comatose severe drug-induced depressed states ( alcohol , barbiturates , narcotics , etc . ) . loxapine contraindicated individuals known hypersensitivity dibenzoxazepines .",
    "ingredients": [
        {
            "name": "AMMONIA",
            "code": "5138Q19F1X"
        },
        {
            "name": "ANHYDROUS LACTOSE",
            "code": "3SY5LH9PMK"
        },
        {
            "name": "BENZYL ALCOHOL",
            "code": "LKG8494WBH"
        },
        {
            "name": "BUTYLPARABEN",
            "code": "3QPI1U3FV8"
        },
        {
            "name": "EDETATE CALCIUM DISODIUM",
            "code": "25IH6R4SGF"
        },
        {
            "name": "FERROSOFERRIC OXIDE",
            "code": "XM0M87F357"
        },
        {
            "name": "GELATIN",
            "code": "2G86QN327L"
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30"
        },
        {
            "name": "METHYLPARABEN",
            "code": "A2I8C7HI9T"
        },
        {
            "name": "POLACRILIN POTASSIUM",
            "code": "0BZ5A00FQU"
        },
        {
            "name": "POTASSIUM HYDROXIDE",
            "code": "WZH3C48M4T"
        },
        {
            "name": "PROPYLENE GLYCOL",
            "code": "6DC9Q167V3"
        },
        {
            "name": "PROPYLPARABEN",
            "code": "Z8IX2SC1OH"
        },
        {
            "name": "SHELLAC",
            "code": "46N107B71O"
        },
        {
            "name": "SODIUM LAURYL SULFATE",
            "code": "368GB5141J"
        },
        {
            "name": "SODIUM PROPIONATE",
            "code": "DK6Y9P42IN"
        },
        {
            "name": "TALC",
            "code": "7SEV7J4R1U"
        },
        {
            "name": "TITANIUM DIOXIDE",
            "code": "15FIX9V2JP"
        },
        {
            "name": "LOXAPINE SUCCINATE",
            "code": "X59SG0MRYU"
        }
    ],
    "organization": "REMEDYREPACK INC.",
    "name": "Loxapine",
    "effectiveTime": "20250528",
    "indications_original": "Loxapine capsules are indicated for the treatment of schizophrenia. The efficacy of loxapine in schizophrenia was established in clinical studies which enrolled newly hospitalized and chronically hospitalized acutely ill schizophrenic patients as subjects.",
    "contraindications_original": "Loxapine capsules are administered, usually in divided doses, two to four times a day. Daily dosage (in terms of base equivalents) should be adjusted to the individual patient’s needs as assessed by the severity of symptoms and previous history of response to antipsychotic drugs.",
    "warningsAndPrecautions_original": "Loxapine capsules, USP are available in the following strengths:\n                  Loxapine succinate, USP 6.8 mg equivalent to 5 mg loxapine, black ink, hard shell, opaque, with a white body and cap, printed with “Watson 369” on one half and “5 mg” on the other, are supplied in\n                  \n                  NDC: 70518-0346-00\n                  PACKAGING: 30 in 1 BLISTER PACK\n                  \n                  \n                  Store at 20° to 25°C (68° to 77°F) [See USP Controlled Room Temperature]. Dispense in a tight, child-resistant container.\n                  \n                  Repackaged and Distributed By:\n                  Remedy Repack, Inc.\n                  625 Kolter Dr. Suite #4 Indiana, PA 1-724-465-8762",
    "adverseReactions_original": "Loxapine is contraindicated in comatose or severe drug-induced depressed states (alcohol, barbiturates, narcotics, etc.).\n                  Loxapine is contraindicated in individuals with known hypersensitivity to dibenzoxazepines."
}